APRALAN DIN 00818542
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | APRAMYCIN (APRAMYCIN SULFATE) 50 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1989 |
|---|
| Current status date | 31-Oct-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing APRAMYCIN (APRAMYCIN SULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02523000 | APRAVET | HUVEPHARMA EOOD | Powder For Solution | APRAMYCIN (APRAMYCIN SULFATE) 552 UNIT | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20433 | 2018-02-02 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 20225 | 2018-01-04 | Supplement to a New Drug Submission (SNDS) | Change to Prescription Status, Labelling updates |
| 3628 | 2004-05-19 | New Drug Submission (NDS) | |
Request a quote for APRALAN
How to read a Canadian DIN record